p53 Expression in Node Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B (CALGB) 9344 Trial (159905)

PURPOSE: p53 as a prognostic and predictive factor in early stage breast cancer, has had mixed results. We studied p53 protein expression, by immunohistochemistry, in a randomized clinical trial of stage II patients treated with adjuvant doxorubicin and cyclophosphamide with or without paclitaxel (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lara, Jonathan F., Thor, Ann D., Dressler, Lynn G., Broadwater, Gloria, Bleiweiss, Ira J., Edgerton, Susan, Cowan, David, Goldstein, Lori J., Martino, Silvana, Ingle, James N., Henderson, I. Craig, Norton, Larry, Winer, Eric P., Hudis, Clifford A., Ellis, Matthew J., Berry, Donald A., Hayes, Daniel F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3149770/
https://ncbi.nlm.nih.gov/pubmed/21693655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados